The Quest to End Heart Disease
Over 120 million Americans live with heart disease, the leading cause of death in the United States.
Behind every statistic is a person fighting for more time, and behind them is a team of scientists, investors, and patient advocates working toward a cure.
The Quest to Treat Scleroderma
Over 100,000 Americans suffer from scleroderma, a disease that causes the immune system to attack the body.
Behind every statistic is a person fighting for more time, and behind them is a team of scientists, investors, and patient advocates working toward a cure.
The Quest to Beat Endometrial Cancer
Over 60,000 women in the United States are diagnosed each year with endometrial cancer, one of the few cancers still with rising mortality rates.
Behind every statistic is a person fighting for more time, and behind them is a team of scientists, investors, and patient advocates working toward a cure.
The Quest to Cure Breast Cancer
Over 3.8 million Americans, mostly women, but also some men are living with breast cancer. Even with available treatments, more than 40,000 women die each year in America, making it the second deadliest cancer.
Behind every statistic is a person fighting for more time, and behind them is a team of scientists, investors, and patient advocates working toward a cure.
The Quest to End Colon Cancer
Over 150,000 Americans are diagnosed with colon cancer every year, making it one of the most common cancers. And it kills over 50,000 Americans each year, making it one of the deadliest.
Behind every statistic is a person fighting for more time, and behind them is a team of scientists, investors, and patient advocates working toward a cure.
The Quest to Defeat Prostate Cancer
Nearly one in eight men in the United States are diagnosed with prostate cancer in their lifetime. Every year, almost 300,000 discover that they have prostate cancer and over 30,000 die from it, making it one of the most survivable cancers and also the second highest cause of cancer death among men.
Behind every statistic is a person fighting for more time, and behind them is a team of scientists, investors, and patient advocates working toward a cure.
The Quest to Combat ALS
Over 30,000 Americans are living with amyotrophic lateral sclerosis (ALS).
Behind every statistic is a person fighting for more time, and behind them is a team of scientists, investors, and patient advocates working toward a cure.
The Quest to Cure Cancer
Over 2 million Americans are diagnosed with cancer each year.
Behind every statistic is a person fighting for more time, and behind them is a team of scientists, investors, and patient advocates working toward a cure.
The Quest to Defeat Blood Cancer
Over 1.5 million Americans are living with blood cancers—leukemia, lymphoma, myeloma. Behind every statistic is a person fighting for more time, and behind them is a team of scientists, investors, and patient advocates working toward a cure.
The Quest to Combat Lupus
More than 1.5 million Americans live with lupus. Meet some of the biotech innovators working to develop new medicines to better treat—and even cure—this disease.
The Quest to Conquer Arthritis
More than 1 million Americans live with rheumatoid arthritis, a painful autoimmune disease that can damage joints, skin, eyes, lungs, and more. Meet some of the biotech innovators working to develop new medicines to better treat—and even cure—this disease.
The Quest to Defeat Cystic Fibrosis
About 40,000 children and adults in the US and approximately a hundred thousand people worldwide live with cystic fibrosis or CF. Meet some of the biotech innovators working to develop new medicines to better treat—and even cure—this disease.
The Quest to Cure Ovarian Cancer
About 20,000 American women are diagnosed with ovarian cancer each year. Meet some of the biotech innovators working to develop new medicines to better treat—and even cure—this disease.
The Quest to End Skin Cancer
Over 3 million Americans are diagnosed with skin cancer each year. Meet some of the biotech innovators working to develop new medicines to better treat—and even cure—this disease.
The Quest to Treat Multiple Sclerosis
Nearly a million Americans are living with multiple sclerosis. Meet some of the biotech innovators working to develop new medicines to restore health and happiness to these patients and their families.
The Quest to Defeat Parkinson’s Disease
Nearly 1 million Americans and over 7 million people globally are living with Parkinson's disease. Meet some of the biotech innovators working to develop new medicines to restore health and happiness to these patients and their families.
The Massachusetts Paradox
The Massachusetts biotech industry leads the world in innovation and drug development. But its companies don’t have the support of its own leaders. Why?
The Quest to Beat Autoimmune Disorders
Biomedical innovators are developing new autoimmune therapeutics - insurance reform will ensure new treatments and cures are accessible and affordable.
A note of thanks to the FDA
An independent and autonomous FDA is a key part of ensuring that the biotech innovation ecosystem can continue to thrive. As an agency, it is the gold standard globally for determining risk-reward benefit in therapies for patients, and the world looks to it to lead the way. The people at the FDA are trying hard to make sure that we actually make progress, and their work is a service to the American public.
Protect American Innovation
America is the global leader in biomedical innovation because it has a market that values new medicines. When other countries pay less, they are free-riding on our willingness to pay for new treatments. Forcing drug manufacturers to charge the same price that these other countries mandate would backfire. Instead, policymakers should use trade negotiations to pressure other wealthy countries to pay their fair share.